Allergy

1. LEILY M, Zhang H, Roberts G, Vijayanand P, et al
   Natural History of Alternaria Sensitisation and Association With Asthma and Rhinitis From Childhood to Adulthood.
   Allergy. 2026 May 18. doi: 10.1111/all.70394.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

2. MOFFATT MF, Nishimura T, Cox MJ, Mcbrien C, et al
   Airway microbiome diversity, intra-mucosal bacteria, and spatial immunity in asthmatics and controls.
   Am J Respir Crit Care Med. 2026 May 9:aamag232. doi: 10.1093.
   

   >> Share

   
   
3. LUGOGO NL, Akuthota P, Sumino K, Burnette AF, et al
   Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.
   Am J Respir Crit Care Med. 2026 May 18:aamag225. doi: 10.1093.
   

   >> Share

   
   

   
   Arch Bronconeumol

4. PEDRO-TUDELA A, Garcia-Ortega A, Martinez-Moragon E
   Pasteurella canis Pneumonia in a Severe Asthmatic Receiving Biologic Therapy: A Zoonotic Complication of Pet-related Anthropomorphism.
   Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00156.
   

   >> Share

   
   

   
   BMC Pediatr

5. BAFUNYEMBAKA G, Nacher M, Makembi A, Maniassom C, et al
   Nutritional status and clinical severity in children with sickle cell disease and confirmed asthma: a multicentre observational study.
   BMC Pediatr. 2026 May 19. doi: 10.1186/s12887-026-06994.
   

   >> Share

   
   

   
   Chest

6. JOE A, Rosser FJ, Gaietto K, Yue M, et al
   Dietary patterns and asthma endotypes in Puerto Rican youth.
   Chest. 2026 May 19:S0012-3692(26)00645-8. doi: 10.1016/j.chest.2026.
   

   >> Share

   
   
7. GRAMEGNA A, Maruca G, Caminati M, Imeri G, et al
   Use of an anti-TSLP agent in patients with asthma and clinically significant bronchiectasis: a case series.
   Chest. 2026 May 14:S0012-3692(26)00635-5. doi: 10.1016/j.chest.2026.
   

   >> Share

   
   

   
   Eur Respir J

8. 
   ERJ Podcast May 2026: Mucus plugs in asthma and COPD.
   Eur Respir J. 2026;67:26E6705.
   

   >> Share

   
   
9. CHALMERS JD, Haworth CS, Flume P, Long MB, et al
   Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?
   Eur Respir J. 2026;67:2600012.
   

   >> Share

   
   
10. PORTACCI A, Ventura L, Menzella F, Poto R, et al
    Small Airway Dysfunction May Mediate the Association Between Body Mass Index and Severe Asthma Exacerbations.
    Eur Respir J. 2026 May 21:2600150. doi: 10.1183/13993003.00150-2026.
    

    >> Share

    
    

    
    J Allergy Clin Immunol

11. KAN-O K, Watanabe H, Chibana K, Suzukawa M, et al
    One-Year Clinical Remission with Tezepelumab in Severe Asthma: TERESA Single-Arm Prospective Study.
    J Allergy Clin Immunol. 2026 May 20:S0091-6749(26)00344.
    

    >> Share

    
    

    
    J Asthma

12. WANG Z, Chen J, Zhang Y, Zhao X, et al
    Revealing shared gene signatures and HIF-1alpha pathway in allergic rhinitis and asthma: a bioinformatics and experimental study.
    J Asthma. 2026 May 15:1-15. doi: 10.1080/02770903.2026.2654630.
    

    >> Share

    
    
13. ZHANG J, Song Y, Mi X, Hu Y, et al
    TRPV1(+) nociceptor neurons promote airway neurogenic inflammation in CVA via substance P-dependent macrophage M1 polarization.
    J Asthma. 2026;63:752-766.
    

    >> Share

    
    

    
    JAMA

14. AGARWAL S, Malani PN
    Advancing Pharmacoequity in Asthma.
    JAMA. 2026 May 18. doi: 10.1001/jama.2026.8185.
    

    >> Share

    
    
15. REN J, Ara AF, Essien UR, Scannell C, et al
    Disparities in Inhaler Utilization Among US Adults With Asthma.
    JAMA. 2026 May 18:e267613. doi: 10.1001/jama.2026.7613.
    

    >> Share

    
    

    
    Lancet

16. PAPI A, Greening NJ, Bhatt SP, Roche N, et al
    Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
    Lancet. 2026;407:2027-2039.
    

    >> Share

    
    

    
    Occup Environ Med

17. MIGUERES N, Dumas O, Boudier A, Bousquet J, et al
    Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.
    Occup Environ Med. 2026;83:100-106.
    

    >> Share

    
    
18. ZIEMBICKI S, Kirkham TL, Arrandale VH, Navaneelan T, et al
    Cancer, chronic obstructive pulmonary disease and ischaemic heart disease in Ontario, Canada workers exposed to diesel engine exhaust.
    Occup Environ Med. 2026;83:78-84.
    

    >> Share

    
    

    
    Pediatr Allergy Immunol

19. MURRY NEWTON A, Handa K, Bloom M, Hendrix-Dicken A, et al
    Medical home access in children with asthma: Association with asthma severity and sociodemographic factors.
    Pediatr Allergy Immunol. 2026;37:e70350.
    

    >> Share

    
    
20. WARDEN DE, Melaram R, Karmaus W, Zhang H, et al
    Prenatal environmental exposures and the risk of repeated childhood wheeze and diagnosed atopic disease.
    Pediatr Allergy Immunol. 2026;37:e70372.
    

    >> Share

    
    

    
    Pediatr Pulmonol

21. VAZ FPC, Braghiroli MMM, Nogueira PCK, Sole D, et al
    Emotional and Behavioral Problems in Children and Adolescents With Asthma and Their Association With Disease Severity.
    Pediatr Pulmonol. 2026;61:e71672.
    

    >> Share

    
    
22. KHALID J, Chen H, Farber HJ
    Association of Inhaled Corticosteroid and Long-Acting Beta Agonist Combination Versus Inhaled Corticosteroid Only Inhalers on Adherence and Asthma Outcomes.
    Pediatr Pulmonol. 2026;61:e71673.
    

    >> Share

    
    
23. LA REGINA DP, Spatuzzo M, Bonci E, Nenna R, et al
    Virus Detection and Hospitalization Rate in Infants With Bronchiolitis After Nirsevimab Introduction: A Retrospective Comparative Two-Season Study.
    Pediatr Pulmonol. 2026;61:e71647.
    

    >> Share

    
    
24. PANTANO-JIMENEZ SC, Rodriguez-Martinez CE, Barrios-Acosta M
    Knowledge, Beliefs, and Perceptions of Asthma in a Population of Caregivers of Asthmatic Children in Bogota, Colombia: A Qualitative Study.
    Pediatr Pulmonol. 2026;61:e71664.
    

    >> Share

    
    

    
    PLoS One

25. ZHANG F, Li H, Wu F, Xian D, et al
    Identifying and validating ITGB2 and HNRNPAB as diagnostic biomarkers in chronic obstructive pulmonary disease using bioinformatics and Integrated Machine Learning Methods.
    PLoS One. 2026;21:e0349338.
    

    >> Share

    
    

    
    Pneumologie

26. LOMMATZSCH M, Buhl R, Brehler R, Hamelmann E, et al
    [Documentation of biological treatment in asthma].
    Pneumologie. 2026 May 18. doi: 10.1055/a-2842-7870.
    

    >> Share

    
    

    
    Respir Med

27. TOFOLI TM, Dorssers B, Vaes AW, Palmen B, et al
    The association of dyspnea and fatigue severity with physical activity and physical capacity in patients with COPD.
    Respir Med. 2026;257:108863.
    

    >> Share

    
    
28. ZHU Q, He R, Wang F, Hu D, et al
    Insulin resistance surrogates and their associations with preserved ratio impaired spirometry in United States adults.
    Respir Med. 2026;257:108860.
    

    >> Share

    
    
29. NI FX, Hu J, Chen PS, Huang DH, et al
    Disulfidptosis in chronic obstructive pulmonary disease: Unraveling a novel immunometabolic nexus for therapeutic targeting.
    Respir Med. 2026;257:108862.
    

    >> Share

    
    
30. SETHI S, Gozalo L, McMorrow D, Feigler N, et al
    Outcomes of patients with COPD before and after initiation of treatment with budesonide/glycopyrrolate/formoterol fumarate: Results from the US ARCTOS study.
    Respir Med. 2026;257:108826.
    

    >> Share

    
    
31. KLOCZL KRING S, Kristensen R, Hoj S, Andersen JR, et al
    YouTube as a source of information on the non-pharmacological treatment of COPD.
    Respir Med. 2026;257:108838.
    

    >> Share

    
    
32. CHEN YC, Zhang S, Hong S, Meah S, et al
    Exhaled breath condensate based breath analyser: Real-time thermofluidic standardisation of hydrogen peroxide for longitudinal COPD monitoring: a pilot investigation.
    Respir Med. 2026;257:108813.
    

    >> Share

    
    
33. LARSON JL, Webster-Dekker KE, Dechert R, Tucker S, et al
    Active for life intervention produces a sustained increase in physical activity in people with chronic obstructive pulmonary disease.
    Respir Med. 2026;257:108818.
    

    >> Share

    
    

    
    Respir Res

34. JIANG L, Li H, Bao W, Zhang A, et al
    Qingre Runzao oral liquid and its key compound ophiopogonin D inhibit CXCL9 and block CXCL9/CXCR3 axis to ameliorate asthma by suppressing RAS/ERK pathway.
    Respir Res. 2026 May 21. doi: 10.1186/s12931-026-03723.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share